What Is the "Wolverine Stack"? (BPC-157 + TB-500)
Neither peptide is FDA approved. No tests in people of the two together.
By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Not yet reviewed by a licensed clinician. How we check facts
Live tracker: is the FDA peptide policy final yet?

Where the name comes from
- Wolverine is a comic book hero who heals very fast.
- Online sellers and influencers use the name for BPC-157 plus TB-500. They say it speeds healing after injuries or workouts.
- A Harvard public health expert calls it "the so-called Wolverine Stack." Some news stories call BPC-157 alone "Wolverine."
What science says
- For BPC-157, the FDA says it has no, or only a little, safety data in people.
- For TB-500, the FDA says it found no data at all from people using it.
- We found no study that tested the two together in people.
- Good results in rats or mice often do not carry over to people. KFF Health News reports that fewer than 1 in 10 things that look good in animals work in human tests.
Is it safe to take BPC-157 and TB-500 together?
- Nobody can say it is safe. We searched PubMed and found no study in people of the two together.
- Two unknowns do not add up to a known. Each one alone has little or no safety data in people, the FDA says.
- Mixing makes it harder to tell which product caused a problem, if one happens.
What extra risks come with stacking them?
- Doubling up: blends like KLOW and GLOW already contain BPC-157 and TB-500. Taking a blend plus a single vial means more than you may think.
- Quality: "research use only" vials are not checked by the FDA for what is inside, or for germs.
- Shots: every shot is a chance for infection or a skin reaction. Two products can mean more shots.
- Cancer questions: BPC-157 helped grow new blood vessels in a lab study, and a TB-4 scientist told KFF Health News that TB-4 does too. Cancer centers say people with cancer should be extra careful.
Reports of harm
- KFF Health News (October 13, 2026) talked with people who say peptides hurt them. One man said he got bad migraines within days of taking BPC-157 with TB-4, a related peptide.
- These are personal stories. They do not prove the peptides caused the harm. But they show why real safety tests matter.
- A heart scientist who studies TB-4 told KFF it helps new blood vessels grow, which might help cancers grow. His study planned to check people for early cancer first.
Is it legal in the US?
- Neither BPC-157 nor TB-500 is FDA approved.
- Both were moved off the FDA’s "Category 2" risky list in April 2026. That is not approval.
- In July 2026, FDA advisers voted to let pharmacies make both. On October 28, 2026, HHS said it will not take action against licensed pharmacies that make BPC-157 or TB-500 with a prescription, under strict rules. But only 1 of its listed peptides is allowed per product, so a BPC-157 + TB-500 blend is not covered.
- Products sold "for research use only" are not made or checked for people. The FDA has warned sellers.
Sports and drug tests
- The World Anti-Doping Agency lists BPC-157 as banned in sport.
- Harvard experts warn that peptides bought online can make you fail a drug test.
Want to compare BPC-157 and TB-500 one by one?
- This page is about taking them together. Our comparison page puts the two side by side: what each is, the studies, and FDA status.
What should I do?
Do not start it on your own. Talk to a doctor first. Bring our printable doctor questions sheet.
Every BPC-157 study in people, added up
30 people in 3 small studies. None compared it with a placebo
People in BPC-157 studiesA 2026 review found these 3 studies
- Knee pain chart review 16
- Bladder pain pilot 12
- Safety pilot (IV) 2
30 people total. For comparison, the semaglutide SELECT heart trial had 17,604 people.
Show the numbers as a table
| All human studies | Knee pain chart review | Bladder pain pilot | Safety pilot (IV) | Total |
|---|---|---|---|---|
| People in BPC-157 studies | 16 | 12 | 2 | 30 |
FAQ
Can you take BPC-157 and TB-500 together?
No study in people has tested BPC-157 and TB-500 together, so nobody knows if the pair is safe or works. Neither is FDA approved. Talk to a doctor before taking either one.
Should BPC-157 and TB-500 be mixed together or taken separately?
Under the October 28, 2026 HHS policy, a licensed pharmacy may make each one only as a single-peptide product, so it may not mix them in one vial. There is no evidence in people for either way of taking them.
Is the Wolverine Stack safe?
Nobody knows. There are no good safety studies in people for BPC-157, TB-500, or the two together.
Is the Wolverine Stack FDA approved?
No. Neither BPC-157 nor TB-500 is FDA approved.
Is the Wolverine Stack legal?
Neither peptide is an approved medicine. Since October 28, 2026, an interim HHS policy covers each one alone, made by a licensed pharmacy with a prescription. It does not cover blends, so a mixed Wolverine Stack vial is not covered.
What is the difference between TB-4 and TB-500?
TB-4 (thymosin beta-4) is a protein your body makes. TB-500 is a small lab-made piece of it. The FDA calls TB-500 a "thymosin beta-4 fragment."
Related pages
- BPC-157Not approved · Proof: Early
- TB-500Not approved · Proof: Animal or lab only
- KPVNot approved · Proof: Animal or lab only
- Thymosin alpha-1Not approved · Proof: Mixed
- BPC-157 vs TB-500: What Is the Difference?Guide
- Peptides for joint pain and arthritis: do they work?Guide
- Peptides vs TRT vs SARMs: which is safer?Guide
- Do peptides really work? The honest answerGuide
- FDA Category 2 Peptide List (2026): Which Peptides Are on It Now?Guide
- KLOW and GLOW peptide blends: what's inside and what science saysGuide
- Can peptides cause cancer? What doctors actually knowGuide
- Is peptide stacking safe? What the studies showGuide
- FDA peptide policy trackerTool
- Do peptides show up on a drug test?Tool
- Compare BPC-157 vs TB-500Comparison tool
We never share doses or tell you where to buy. Always ask your doctor. Print our doctor questions sheet.
Sources
- Harvard T.H. Chan School of Public Health: Peptides are all over social media (Oct 1, 2026)
- KFF Health News: People say these peptides hurt them (Oct 13, 2026)
- FDA: Bulk drug substances that may present significant safety risks
- FDA: Bulk drug substances nominated for 503A compounding (category lists, updated May 14, 2026)
- FDA: July 23-24, 2026 Pharmacy Compounding Advisory Committee meeting
- Reginfo.gov: Interim Access Policy for Compounding Using Certain Peptides (RIN 0910-ZD94)
- WADA Prohibited List
- HHS: Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (Oct 28, 2026)
- Federal Register (public inspection): FR Doc. 2026-22192, HHS peptide compounding policy